These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26266124)

  • 1. Giant Platelets in Platelet Donors - A Blessing in Disguise?
    Roy AD; Choudhury N; Ray D
    J Clin Diagn Res; 2015 Jun; 9(6):EC01-3. PubMed ID: 26266124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet and red blood cell indices in Harris platelet syndrome.
    Naina HV; Harris S
    Platelets; 2010; 21(4):303-6. PubMed ID: 20201635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of Platelet Count among Apheresis Platelet Donors.
    Thokala RP; Radhakrishnan K; Anandan A; Panicker VK
    J Clin Diagn Res; 2016 Dec; 10(12):EC01-EC04. PubMed ID: 28208861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of double dose plateletpheresis on target yield and donor platelet recovery.
    Chopra S; Kaur P; Bedi RK; Kaur G
    Hematol Transfus Cell Ther; 2023; 45(1):16-24. PubMed ID: 34294601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in hematological parameters post plateletpheresis: Single center study from North India.
    Rajput S; Makroo RN; Chowdhry M; Thakur UK
    Transfus Apher Sci; 2021 Dec; 60(6):103283. PubMed ID: 34625349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of initial values of donor platelets count on the efficiency of plateletpheresis with the cell separator Fenval Baxter Amicus s.v.2.51].
    Landzo E; Berbić-Fazlagić J; Sofo-Hafizović A
    Med Arh; 2009; 63(2):67-70. PubMed ID: 19537658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective quality evaluation of single donor platelets (SDP) - an experience of a tertiary healthcare center in India.
    Pandey P; Tiwari AK; Sharma J; Singh MB; Dixit S; Raina V
    Transfus Apher Sci; 2012 Apr; 46(2):163-7. PubMed ID: 22365925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference interval of platelet counts and other platelet indices in apparently healthy blood donors in North India according to Clinical and Laboratory Standards Institute guidelines: Need to redefine the platelet count cutoffs for repeat plateletpheresis donation?
    Pabbi S; Tiwari AK; Aggarwal G; Sharma G; Marik A; Luthra AS; Upadhyay AP; Singh MK
    Asian J Transfus Sci; 2022; 16(2):245-250. PubMed ID: 36687539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immature Platelet Count Levels as a Novel Quality Marker in Plateletpheresis.
    Unay Demirel O; Ignak S; Buyukuysal MC
    Indian J Hematol Blood Transfus; 2018 Oct; 34(4):684-690. PubMed ID: 30369741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated platelet collection using the latest apheresis devices in an Indian setting.
    Agarwal P; Verma A
    Transfus Apher Sci; 2009 Oct; 41(2):135-8. PubMed ID: 19709930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Era of blood component therapy: time for mandatory pre-donation platelet count for maximizing donor safety and optimizing quality of platelets.
    Das SS; Zaman RU; Biswas D
    Transfus Apher Sci; 2013 Dec; 49(3):640-3. PubMed ID: 23928130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans.
    Stohlawetz P; Horvath M; Pernerstorfer T; Nguyen H; Vondrovec B; Robisch A; Eichler HG; Spitzauer S; Jilma B
    Transfusion; 1999 May; 39(5):506-14. PubMed ID: 10336001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of the levels of reticulated platelets after plateletpheresis to monitor activity of thrombopoiesis.
    Stohlawetz P; Stiegler G; Jilma B; Dettke M; Höcker P; Panzer S
    Transfusion; 1998 May; 38(5):454-8. PubMed ID: 9633558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of evalution of haematocrit in plateletpheresis donors.
    Mane VB; Jagtap PE; Nagane NS; Dhonde SP; Belwalkar GJ; Mane VP
    J Clin Diagn Res; 2015 Apr; 9(4):BC06-7. PubMed ID: 26023547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing yield of plateletpheresis using intermittent flow cell separator.
    DAS SS; Chaudhary RK; Shukla JS
    Clin Lab Haematol; 2005 Oct; 27(5):316-9. PubMed ID: 16178912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postdonation platelet counts are safe when collecting platelets with the Trima Accel using a postdonation platelet count target of > or =50,000 platelets/microL.
    Alex J; Roberts B; Raife T
    J Clin Apher; 2009; 24(5):215-7. PubMed ID: 19816960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.